Top Markets
Coin of the day
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

ZIOP
Rank in Stocks #20771
ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to... ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing innovative immuno-oncology treatments for cancer patients. The company leverages its proprietary Sleeping Beauty platform, which employs non-viral genetic engineering to modify T-cells outside the body using a transposon/transposase system for subsequent infusion. Additionally, ZIOPHARM is advancing its Controlled IL-12 technology, designed to precisely regulate the expression of interleukin-12 (IL-12), a key immune system regulator, to direct the patient's immune response against cancer cells. Its pipeline features several promising therapeutic candidates, including T-cell receptor (TCR) plus T-cell therapies aimed at solid tumors, chimeric antigen receptor (CAR) T-cell therapies specifically targeting CD19 for hematologic malignancies, and Ad-RTS-hIL-12 combined with veledimex, a gene delivery system for controlled IL-12 production under investigation for treating recurrent adult glioblastoma multiforme. ZIOPHARM maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., and research and development agreements, alongside patent licensing, with institutions such as The University of Texas MD Anderson Cancer Center and the National Cancer Institute. The company's headquarters are located in Boston, Massachusetts.
Share Price
$0.8657
Last synced: 2022-01-26
Market Cap
$122.22M
Change (1 day)
-0.88%
Change (1 year)
0.00%
Country
US
Trade ZIOPHARM Oncology, Inc. (ZIOP)

Category

Stock price history for ZIOPHARM Oncology, Inc. (ZIOP)
Highest end of day price: $0.95 on 2022-01-01

Lowest end of day price: $5.02 on 2006-09-01
Stock price history of ZIOPHARM Oncology, Inc. from 2006 to 2026
Annual Stock Price Performance
Year Performance
2022 -23.02%
2021 -56.03%
2020 -44.13%
2019 97.81%
2018 -40.03%
2017 -31.39%
2016 -34.33%
2015 115.72%
2014 7.85%
2013 -2.45%
2012 -8.50%
2011 -1.08%
2010 50.36%
2009 290.84%
2008 -73.45%
2007 -52.27%
2006 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.14 -15.28%
AU
$770.19 8.98%
CH